BRPI0411353A - moléculas de corina modificadas tendo seqüências de ativação substitutas e aplicações das mesmas - Google Patents
moléculas de corina modificadas tendo seqüências de ativação substitutas e aplicações das mesmasInfo
- Publication number
- BRPI0411353A BRPI0411353A BRPI0411353-5A BRPI0411353A BRPI0411353A BR PI0411353 A BRPI0411353 A BR PI0411353A BR PI0411353 A BRPI0411353 A BR PI0411353A BR PI0411353 A BRPI0411353 A BR PI0411353A
- Authority
- BR
- Brazil
- Prior art keywords
- molecules
- modified
- corina
- applications
- activation sequences
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
- C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
- C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
- C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
- C12N9/6424—Serine endopeptidases (3.4.21)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/975—Kit
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Urology & Nephrology (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
"MOLéCULAS DE CORINA MODIFICADAS TENDO SEQüêNCIAS DE ATIVAçãO SUBSTITUTAS E APLICAçõES DAS MESMAS". Esta invenção se refere a novas moléculas corina modificadas, ou fragmentos ou derivados das mesmas, compreendendo uma seqüência de ativação substituta. As moléculas corina modificadas são clivadas em uma seqüência de ativação substituta, deste modo produzindo moléculas corina ativadas, ou fragmentos ou derivados das mesmas, que apresentam a atividade funcional de moléculas corina selvagens, que ocorrem naturalmente. As moléculas corina modificadas podem ser usadas para tratar uma varidade de doenças ou distúrbios, inclusive falência cardíaca congestiva e enfarte agudo do miocárdio.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US47768303P | 2003-06-11 | 2003-06-11 | |
PCT/US2004/018669 WO2004111225A1 (en) | 2003-06-11 | 2004-06-09 | Novel modified corin molecules having substitute activation sequences and uses thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0411353A true BRPI0411353A (pt) | 2006-07-11 |
Family
ID=33551745
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0411353-5A BRPI0411353A (pt) | 2003-06-11 | 2004-06-09 | moléculas de corina modificadas tendo seqüências de ativação substitutas e aplicações das mesmas |
Country Status (15)
Country | Link |
---|---|
US (1) | US7176013B2 (pt) |
EP (1) | EP1636356A1 (pt) |
JP (1) | JP2007502132A (pt) |
KR (1) | KR20060022683A (pt) |
CN (2) | CN101109011A (pt) |
AU (1) | AU2004248192A1 (pt) |
BR (1) | BRPI0411353A (pt) |
CA (1) | CA2527361A1 (pt) |
IL (1) | IL172095A0 (pt) |
MX (1) | MXPA05013321A (pt) |
NO (1) | NO20060144L (pt) |
PL (1) | PL379196A1 (pt) |
RU (1) | RU2006100035A (pt) |
WO (1) | WO2004111225A1 (pt) |
ZA (1) | ZA200600224B (pt) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050026255A1 (en) * | 2002-06-25 | 2005-02-03 | Morser John Michael | Corin, a serine protease |
TW200723151A (en) * | 2005-12-07 | 2007-06-16 | Era Digital Media Co | Business website method |
US20110160128A1 (en) * | 2008-03-28 | 2011-06-30 | Qingyu Wu | Corin for Treating Obesity and Diabetes |
US20110306069A1 (en) | 2009-02-19 | 2011-12-15 | Qingyu Wu | Corin As A Marker For Heart Failure |
US10314894B2 (en) * | 2014-02-12 | 2019-06-11 | The Cleveland Clinic Foundation | Treatment of cardio-renal disease using PCSK6 |
KR102493894B1 (ko) | 2016-02-29 | 2023-01-31 | 리제너론 파마슈티칼스 인코포레이티드 | 인간화 tmprss 유전자를 갖는 설치류 |
CN105734070A (zh) * | 2016-04-11 | 2016-07-06 | 苏州大学 | Corin基因变异体及其用途 |
CN108066286B (zh) * | 2016-11-10 | 2021-06-29 | 复旦大学 | 炔丙基半胱氨酸纳米粒长循环脂质体及其制备方法和用途 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FI882407A (fi) * | 1987-05-22 | 1988-11-23 | Zymogenetics Inc | Fibrinolytiska proteiner. |
US5869637A (en) * | 1996-07-22 | 1999-02-09 | Incyte Pharmaceuticals, Inc. | Human Kallikrein |
WO1998024886A1 (en) * | 1996-12-04 | 1998-06-11 | Brigham And Women's Hospital, Inc. | Mast cell protease that cleaves fibrinogen |
WO1998036054A1 (en) * | 1997-02-13 | 1998-08-20 | Amrad Operations Pty. Ltd. | Novel molecules |
DK1012307T3 (da) * | 1997-08-22 | 2005-09-05 | Roche Diagnostics Gmbh | Autokatalytisk aktiverbare zymogene proteaseforstadier og deres anvendelse |
EP0927764B1 (de) | 1997-12-03 | 2004-05-26 | Boehringer Mannheim Gmbh | Chimäre Serinproteasen |
HUP0102811A3 (en) | 1998-06-05 | 2005-11-28 | Schering Ag | Corin, a serine protease |
US6420157B1 (en) * | 1999-04-30 | 2002-07-16 | Ortho-Mcneil Pharmaceutical, Inc. | Zymogen activation system |
ATE496123T1 (de) * | 2000-02-03 | 2011-02-15 | Dendreon Corp | Nukleinsäuren, welche für tramsmembran serin proteasen kodieren, die kodierten proteine und darauf basierende methoden |
JP2004503219A (ja) * | 2000-06-19 | 2004-02-05 | ダイアックス コーポレーション | 新規エンテロキナーゼ開裂配列 |
SK6312002A3 (en) * | 2000-09-04 | 2002-09-10 | Hyo-Joon Kim | Mimetic peptides for epitope of apolipoprotein b-110, concatemer and modified peptides thereof, and the vaccine composition comprising the same |
FR2831170B1 (fr) * | 2001-10-19 | 2004-03-19 | Inst Nat Sante Rech Med | Proteines c modifiees activables directement par la thrombine |
EP1558731A4 (en) * | 2002-10-04 | 2007-01-10 | Schering Ag | MODIFIED HEPSINE MOLECULES COMPRISING A SUBSTITUTION ACTIVATION SEQUENCE AND USES THEREOF |
-
2004
- 2004-06-09 EP EP04755046A patent/EP1636356A1/en not_active Withdrawn
- 2004-06-09 CN CNA2007101280546A patent/CN101109011A/zh active Pending
- 2004-06-09 KR KR1020057023612A patent/KR20060022683A/ko not_active Application Discontinuation
- 2004-06-09 CN CNA2004800230099A patent/CN1836037A/zh active Pending
- 2004-06-09 BR BRPI0411353-5A patent/BRPI0411353A/pt not_active IP Right Cessation
- 2004-06-09 US US10/865,978 patent/US7176013B2/en not_active Expired - Fee Related
- 2004-06-09 MX MXPA05013321A patent/MXPA05013321A/es not_active Application Discontinuation
- 2004-06-09 JP JP2006533746A patent/JP2007502132A/ja active Pending
- 2004-06-09 RU RU2006100035/13A patent/RU2006100035A/ru not_active Application Discontinuation
- 2004-06-09 WO PCT/US2004/018669 patent/WO2004111225A1/en active Application Filing
- 2004-06-09 PL PL379196A patent/PL379196A1/pl not_active Application Discontinuation
- 2004-06-09 AU AU2004248192A patent/AU2004248192A1/en not_active Abandoned
- 2004-06-09 CA CA002527361A patent/CA2527361A1/en not_active Abandoned
-
2005
- 2005-11-22 IL IL172095A patent/IL172095A0/en unknown
-
2006
- 2006-01-10 NO NO20060144A patent/NO20060144L/no not_active Application Discontinuation
- 2006-01-10 ZA ZA200600224A patent/ZA200600224B/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP1636356A1 (en) | 2006-03-22 |
CA2527361A1 (en) | 2004-12-23 |
WO2004111225A8 (en) | 2006-04-06 |
WO2004111225A1 (en) | 2004-12-23 |
KR20060022683A (ko) | 2006-03-10 |
IL172095A0 (en) | 2009-02-11 |
AU2004248192A1 (en) | 2004-12-23 |
CN101109011A (zh) | 2008-01-23 |
US20050003416A1 (en) | 2005-01-06 |
US7176013B2 (en) | 2007-02-13 |
NO20060144L (no) | 2006-01-10 |
CN1836037A (zh) | 2006-09-20 |
MXPA05013321A (es) | 2006-03-09 |
RU2006100035A (ru) | 2006-08-27 |
PL379196A1 (pl) | 2006-07-24 |
ZA200600224B (en) | 2007-04-25 |
JP2007502132A (ja) | 2007-02-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE446313T1 (de) | Muteine von tränen-lipocalin | |
HUE039881T2 (hu) | 1L1RL-1, mint egy kardiovaszkuláris betegség-marker | |
BRPI0407454A (pt) | Pirazóis e métodos de preparar e usar os mesmos | |
DE60143292D1 (de) | Varianten des menschlichen Koagulationsfaktors VII | |
MY149505A (en) | Hyaluronic acid binary mixtures and therapeutic use thereof | |
BR0108452A (pt) | Inibidores da oxidação parcial de ácido graxo no tratamento de insuficiência cardìaca congestiva | |
DE60315847D1 (de) | Varianten des menschliche koagulationsfaktors vii | |
WO2002038794A3 (en) | Cardiovascular disease diagnostic and therapeutic targets | |
NO20031129D0 (no) | Varianter av human koagulasjonsfaktor VII | |
ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
EA200401341A1 (ru) | Применение остеопротегерина для лечения и/или профилактики фиброзного заболевания | |
BRPI0411353A (pt) | moléculas de corina modificadas tendo seqüências de ativação substitutas e aplicações das mesmas | |
DK1715900T3 (da) | Kompositstrukturer, som indeholder hyaluronsyre derivaterne deraf som nye knoglesubstitutter og -transplantater | |
BR9807936A (pt) | Preparação farmacêutica imuno-tolerante de complexo de pró-trombina, processo para a produção de uma preparação, e, utilização de uma preparação | |
NO20054346L (no) | Sammensetninger og fremgangsmater for forebygging og behandling av endotoksinrelaterte sykdommer og tilstander | |
ATE395602T1 (de) | Verwendung von hmgb-proteinen und dafür codierenden nukleinsäuren | |
WO2000072023A3 (en) | Diagnosis and treatment of atherosclerosis and coronary heart disease | |
DE60108076D1 (de) | Protein c derivate | |
EP2275118A3 (en) | Pancreas-specific proteins | |
DE60335980D1 (de) | Verfahren zur herstellung von synthetischen derivaten von dibenzylbutyrolacton-lignanen mit antichagas eigenschaften | |
FR2860234B1 (fr) | Nouveaux derives 666 du thioxylose | |
BR0113623A (pt) | Proteìnas sintéticas de estìmulo da eritropoiese | |
DE60222669D1 (de) | Asthma-assoziiertes gen | |
BR0214694A (pt) | 1,3-diarilprop-2-en-1-onas, composições que as contêm e utilização | |
EA200401358A1 (ru) | 2,5-бис-диамин-[1,4]бензохиноновые производные для лечения болезни альцгеймера, способ их получения и промежуточные продукты |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012. |